Ikeda, M., Terashima, T., Yamashita, T., Okusaka, T., Imaoka, H., Kawaoka, T., Kobayashi, S., Ogasawara, S., Hiraoka, A., Nakano, M., Nagashima, F., Sugimoto, R., Moriguchi, M., Inaba, Y., Shinoda, S., Ueno, M., Kato, N., Kudo, M., Furuse, J., Nagano, H. (2025). A multicenter, phase 2 study of atezolizumab plus bevacizumab (atezo+bev) combination therapy in patients with unresectable hepatocellular carcinoma (HCC) and Child–Pugh class B cirrhosis: CHALLENGE trial final results.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.4_suppl.587